tirzepatide and bimagrumab Can We Improve the Quality of Weight Loss by Augmenting Fat Mass Loss While Preserving Lean Mass? The BELIEVE Study of + Semaglutide Phase 2 Study of Bimagrumab
Description
November 2025: FDA approved expanded Zepbound (tirzepatide) indication for moderate-to-severe obstructive sleep apnea in adults with obesity, following SURMOUNT-OSA trial data showing 62.8% reduction in apnea-hypopnea index the first drug approval for sleep apnea treatment

per week of weight loss

Avoid overeating
Additionally, metformin enhances insulin sensitivity in peripheral tissues, particularly skeletal muscle, improving glucose uptake and utilization

You may need a backup birth control plan while on these medications

Most pay $0 out-of-pocket Book an appointment with a dietitian Find safe ways to support gut health while on GLP-1 therapy Managing digestion on GLP-1 medications like tirzepatide often involves small, sustainable lifestyle adjustments
